Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

STRUER FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.7% 2.0% 2.8% 1.4% 1.1% 1.4% 11.4% 11.2%   Credit score (0-100)   75 71 59 78 83 76 21 22   Credit rating   A A BBB A A A BB BB   Credit limit (kDKK)   1.9 0.2 0.0 16.3 71.5 12.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,355 2,117 2,624 2,573 2,955 2,928 0.0 0.0   EBITDA   1,479 1,176 1,656 1,406 1,563 1,481 0.0 0.0   EBIT   1,205 883 1,464 1,285 1,501 1,406 0.0 0.0   Pre-tax profit (PTP)   1,250.1 913.5 1,509.0 1,327.9 1,533.5 1,423.5 0.0 0.0   Net earnings   971.5 710.4 1,175.2 1,024.4 1,194.8 1,105.7 0.0 0.0   Pre-tax profit without non-rec. items   1,250 914 1,509 1,328 1,533 1,424 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   343 244 271 197 246 390 0.0 0.0   Shareholders equity total   499 329 525 649 644 817 687 687   Interest-bearing liabilities   398 343 38.4 59.7 193 0.0 0.0 0.0   Balance sheet total (assets)   1,693 1,750 1,919 1,616 1,648 2,297 687 687   Net Debt   392 339 -207 57.9 -325 -540 -687 -687     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,355 2,117 2,624 2,573 2,955 2,928 0.0 0.0   Gross profit growth   -10.3% -10.1% 24.0% -1.9% 14.9% -0.9% -100.0% 0.0%   Employees   3 3 3 4 6 5 0 0   Employee growth %   0.0% 0.0% 0.0% 33.3% 50.0% -16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,693 1,750 1,919 1,616 1,648 2,297 687 687   Balance sheet change%   -24.4% 3.4% 9.7% -15.8% 2.0% 39.4% -70.1% 0.0%   Added value   1,479.4 1,175.6 1,656.2 1,405.7 1,622.5 1,480.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -290 -472 -245 -196 -12 69 -390 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.1% 41.7% 55.8% 49.9% 50.8% 48.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   65.2% 54.4% 83.0% 75.5% 94.7% 72.2% 0.0% 0.0%   ROI %   119.3% 119.1% 246.5% 210.0% 200.0% 172.1% 0.0% 0.0%   ROE %   156.4% 171.5% 275.3% 174.6% 184.9% 151.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   29.5% 18.8% 27.3% 40.1% 39.1% 35.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   26.5% 28.8% -12.5% 4.1% -20.8% -36.5% 0.0% 0.0%   Gearing %   79.8% 104.1% 7.3% 9.2% 30.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.1% 6.3% 6.8% 15.3% 9.5% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.0 1.1 1.3 1.6 1.8 1.4 0.0 0.0   Current Ratio   1.3 1.2 1.6 2.1 2.1 1.6 0.0 0.0   Cash and cash equivalent   6.0 3.6 245.1 1.8 518.4 540.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   302.9 232.3 603.1 756.7 733.9 720.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   493 392 552 351 270 296 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   493 392 552 351 260 296 0 0   EBIT / employee   402 294 488 321 250 281 0 0   Net earnings / employee   324 237 392 256 199 221 0 0